News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
372,724 Results
Type
Article (27051)
Company Profile (121)
Press Release (345543)
Multimedia
Podcasts (52)
Webinars (18)
Section
Business (114373)
Career Advice (1302)
Deals (16599)
Drug Delivery (92)
Drug Development (41700)
Employer Resources (159)
FDA (8865)
Job Trends (8653)
News (170276)
Policy (15247)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (1963)
Academic (2)
Accelerated approval (39)
ADA (25)
Adcomms (19)
Allergies (168)
Alliances (29027)
ALS (157)
Alzheimer's disease (1175)
Antibody-drug conjugate (ADC) (310)
Approvals (9382)
Artificial intelligence (489)
ASCO (180)
Autoimmune disease (236)
Automation (43)
Bankruptcy (94)
Best Places to Work (7156)
BIO (47)
BIOSECURE Act (13)
Biosimilars (192)
Biotechnology (73)
Bladder cancer (155)
Brain cancer (43)
Breast cancer (462)
Cancer (3692)
Cardiovascular disease (317)
Career advice (1172)
Career pathing (48)
CAR-T (205)
CDC (30)
Cell therapy (597)
Cervical cancer (39)
Clinical research (37686)
Collaboration (1576)
Company closure (1)
Compensation (602)
Complete response letters (45)
COVID-19 (1464)
CRISPR (83)
C-suite (957)
Cystic fibrosis (127)
Data (5741)
Decentralized trials (2)
Denatured (30)
Depression (108)
Dermatology (81)
Diabetes (398)
Diagnostics (3838)
Digital health (36)
Diversity (10)
Diversity, equity & inclusion (38)
Drug discovery (272)
Drug pricing (83)
Drug shortages (8)
Duchenne muscular dystrophy (200)
Earnings (33548)
Editorial (28)
Employer branding (23)
Employer resources (139)
Events (56065)
Executive appointments (846)
FDA (11672)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (15)
Frontotemporal dementia (13)
Funding (1316)
Gene editing (168)
Generative AI (43)
Gene therapy (517)
GLP-1 (558)
Government (2430)
Grass and pollen (2)
Guidances (254)
Healthcare (9900)
Hematology (130)
HIV (68)
Huntington's disease (35)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (94)
Immunology and inflammation (130)
Immuno-oncology (47)
Indications (133)
Infectious disease (1681)
Inflammatory bowel disease (174)
Inflation Reduction Act (10)
Influenza (83)
Intellectual property (184)
Interviews (197)
IPO (7151)
IRA (20)
Job creations (1710)
Job search strategy (993)
JPM (34)
Kidney cancer (5)
Labor market (105)
Layoffs (242)
Leadership (31)
Legal (2812)
Liver cancer (64)
Longevity (25)
Lung cancer (474)
Lymphoma (301)
Machine learning (41)
Management (54)
Manufacturing (697)
Marketing (4)
MASH (98)
Medical device (6816)
Medtech (6922)
Mergers & acquisitions (10361)
Metabolic disorders (860)
mRNA (116)
Multiple sclerosis (135)
NASH (11)
Neurodegenerative disease (278)
Neuropsychiatric disorders (49)
Neuroscience (2240)
Neurotech (1)
NextGen: Class of 2026 (3536)
Non-profit (3278)
Now hiring (80)
Obesity (347)
Opinion (196)
Ovarian cancer (154)
Pain (177)
Pancreatic cancer (193)
Parkinson's disease (280)
Partnered (25)
Patents (314)
Patient recruitment (494)
Peanut (60)
People (36966)
Pharmaceutical (32)
Pharmacy benefit managers (12)
Phase 1 (10815)
Phase 2 (16172)
Phase 3 (13909)
Pipeline (6437)
Policy (153)
Postmarket research (1331)
Preclinical (4624)
Press Release (62)
Prostate cancer (216)
Psychedelics (32)
Radiopharmaceuticals (168)
Rare diseases (854)
Real estate (3503)
Recruiting (65)
Regulatory (13698)
Reports (54)
Research institute (1776)
Resumes & cover letters (164)
Rett syndrome (41)
RNA editing (17)
RSV (63)
Schizophrenia (125)
Series A (243)
Series B (149)
Service/supplier (5)
Sickle cell disease (90)
Special edition (14)
Spinal muscular atrophy (124)
Sponsored (30)
Startups (2530)
State (1)
Stomach cancer (9)
Supply chain (74)
Tariffs (20)
The Weekly (22)
Vaccines (546)
Venture capital (104)
Weight loss (189)
Women's health (87)
Worklife (22)
Date
Today (40)
Last 7 days (287)
Last 30 days (1160)
Last 365 days (18425)
2026 (10402)
2025 (18204)
2024 (20811)
2023 (23456)
2022 (29596)
2021 (32144)
2020 (29977)
2019 (25769)
2018 (19179)
2017 (17669)
2016 (17000)
2015 (19156)
2014 (14083)
2013 (11539)
2012 (12126)
2011 (12499)
2010 (11450)
Location
Africa (521)
Alabama (59)
Alaska (6)
Arizona (187)
Arkansas (11)
Asia (33111)
Australia (4829)
California (8098)
Canada (2324)
China (1018)
Colorado (349)
Connecticut (356)
Delaware (295)
Europe (55007)
Florida (1219)
Georgia (253)
Hawaii (3)
Idaho (24)
Illinois (604)
India (89)
Indiana (510)
Iowa (22)
Japan (561)
Kansas (65)
Kentucky (34)
Louisiana (31)
Maine (20)
Maryland (906)
Massachusetts (6131)
Michigan (206)
Minnesota (402)
Mississippi (6)
Missouri (73)
Montana (20)
Nebraska (13)
Nevada (100)
New Hampshire (22)
New Jersey (2568)
New Mexico (19)
New York (2294)
North Carolina (1198)
North Dakota (10)
Northern California (4088)
Ohio (265)
Oklahoma (16)
Oregon (31)
Pennsylvania (1521)
Puerto Rico (18)
Rhode Island (27)
South America (657)
South Carolina (18)
Southern California (3204)
Tennessee (120)
Texas (1156)
United States (29152)
Utah (189)
Vermont (2)
Virginia (214)
Washington D.C. (51)
Washington State (573)
West Virginia (2)
Wisconsin (116)
Wyoming (1)
372,724 Results for "tiziana life sciences ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - June 15, 2026
June 15, 2026
·
2 min read
Press Releases
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York 2026
May 28, 2026
·
4 min read
Press Releases
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
April 14, 2026
·
5 min read
Press Releases
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
April 16, 2026
·
6 min read
Press Releases
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
December 22, 2025
·
2 min read
Press Releases
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
January 16, 2026
·
6 min read
Press Releases
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
January 21, 2026
·
6 min read
Press Releases
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
June 25, 2026
·
6 min read
Press Releases
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
January 19, 2026
·
5 min read
Press Releases
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial
December 18, 2025
·
5 min read
1 of 37,273
Next
